XTLB XTL Biopharmaceuticals
- 2.040
- -0.135-6.21%
- 2.110
- +0.070+3.43%
XTL Biopharmaceuticals News
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
